[Progress of targeted therapy in macrophage activation syndrome secondary to autoimmune diseases]

H Jiang1, C H Wang1, S Y Chen1

  • 1Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China.

Zhonghua Nei Ke Za Zhi
|December 2, 2021
PubMed
Abstract

No abstract available in PubMed .